Inositol Treatment in Different Type of PCOS Phenotype

Lo.Li.Pharma

Status: Completed

Conditions: Polycystic Ovary Syndrome

Treatments: Dietary Supplement: Myo-inositol

Study type: Interventional

Funder types: Industry

Identifiers

NCT05678114

Ins-PCOSphenotype

Details and patient eligibility

About

Evaluation of the efficacy of inositol treatment in women with PCOS in relation to the phenotype (according to the Rotterdam Criteria)

Enrollment: 120 patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• women with PCOS of any phenotype

Exclusion criteria

• hormonal treatment (such as contraceptive pill)
• use of supplements containing myo-inositol
• severe co-morbidities

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

120 participants in 2 patient groups

Hyperandrogenic PCOS

Experimental group

Treatment:

Dietary Supplement: Myo-inositol

Non-hyperandrogenic PCOS

Experimental group

Treatment:

Dietary Supplement: Myo-inositol